Following its denial of Actavis’ claim for declarations of non-infringement in respect of Eli Lilly’s European Patent, the Court of Appeal ruled on a number of procedural matters arising from that judgment.  These included the form of order for costs of the trial and the appeal; a reduction in an interim payment made by Lilly in the court below; a refusal to include a recital of a contractual undertaking in the order; and refusal of permission to appeal to the Supreme Court.

A full summary of this case has been published on Kluwer IP Law.